Skip to main content
AmigoFish

Episode 218 - JD Finley & Mitch Jones - Palisade Bio

From The BioHub - by Avetix · · 23 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

On this episode we're joined by Palisade Bio's CEO & CMO, JD Finley & Mitch Jones.

In Q2 2026, Palisade released promising ph1 data for their lead asset - PALI2108 - a PDE4 inhibitor. With recent IND clearance for their ph2 ASCENTRA-UC study, we discuss that data, and what real success looks like clinically & commercially for the business & asset moving forward, in an increasingly busy IBD market.

We hope you enjoy the episode.

Back to The BioHub - by Avetix · Report a problem